In mid-December, local news organizations reported that India's Union Cabinet approved an amendment to the nation's Drugs and Cosmetics Act to establish the death penalty for individuals involved in manufacturing, selling or dealing fake pharmaceuticals. The Bill will next be introduced to Parliament.